Clinical significance of plasma aldosterone concentration in patients with primary aldosteronism

Clinical significance of plasma aldosterone concentration in patients with primary aldosteronism - Clinical significance of plasma aldosterone concentration in patients with primary aldosteronism

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016201

Enrollment

750

Registered

2015-01-13

Start date

2015-01-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who has diagnosed primary aldosteronism between January 2004 and December 2015 Patients who has diagnosed essential hypertension between January 2004 and December 2013

Exclusion criteria

Exclusion criteria: Non

Design outcomes

Primary

Measure	Time frame
Clinical features and Cardio- and cerebro-vascular events	—

Countries

Japan

Contacts

Public ContactTetsuhiro Kitamura

Osaka University Graduate School of Medicine Department of Metabolic Medicine

tkitamura@endmet.med.osaka-u.ac.jp06-6879-3742

Outcome results